Production (Stage)
ZYUS Life Sciences Corporation
ZLSCF
$0.5046
-$0.0454-8.26%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.39M | -26.86M | -27.12M | -30.36M | -31.46M |
| Total Depreciation and Amortization | 2.16M | 2.19M | 2.23M | 2.15M | 2.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.78M | 14.95M | 14.63M | 18.06M | 19.37M |
| Change in Net Operating Assets | 1.29M | 4.32M | -465.80K | -3.93M | -3.56M |
| Cash from Operations | -7.16M | -5.40M | -10.72M | -14.09M | -13.34M |
| Capital Expenditure | -34.00K | -174.40K | -192.40K | -196.90K | -207.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 3.66M | 3.66M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.34M | -47.00K | -47.00K | -47.00K | -47.00K |
| Cash from Investing | 1.30M | -221.50K | -239.50K | 3.42M | 3.41M |
| Total Debt Issued | 5.70M | 700.00K | 400.00K | 18.79M | 21.24M |
| Total Debt Repaid | -3.04M | -3.36M | -1.31M | -4.39M | -4.11M |
| Issuance of Common Stock | 3.31M | 3.31M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.28M | 476.00K | -679.70K | 10.73M | 12.75M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.58M | -5.14M | -11.64M | 60.80K | 2.82M |